Cadrenal Therapeutics, Inc. (CVKD) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 03, 2026. The…
Read more
